• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Recognized Consensus Standards

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

New Search Back To Search Results
Part B: Supplementary Information Sheet (SIS)
FR Recognition List Number 050 Date of Recognition 09/17/2018 
FR Recognition Number 1-140
Standard
ISO 80601-2-55 Second edition 2018-02
Medical electrical equipment - Part 2-55: Particular requirements for the basic safety and essential performance of respiratory gas monitors
Scope/Abstract
ISO 80601-2-55:2018 specifies particular requirements for the basic safety and essential performance of a respiratory gas monitor (rgm), hereafter referred to as me equipment, intended for continuous operation for use with a patient.

ISO 80601-2-55:2018 specifies requirements for

- anaesthetic gas monitoring,

- carbon dioxide monitoring, and

- oxygen monitoring.

NOTE 1 An rgm can be either stand-alone me equipment or integrated into other equipment, e.g. an anaesthetic workstation or a ventilator.

ISO 80601-2-55:2018 is not applicable to an rgm intended for use with flammable anaesthetic agents.

If a clause or subclause is specifically intended to be applicable to me equipment only or to me systems only, the title and content of that clause or subclause will say so. If that is not the case, the clause or subclause applies both to me equipment and to me systems, as relevant.

Hazards inherent in the intended physiological function of me equipment or me systems within the scope of this document are not covered by specific requirements in this document except in IEC 60601‑1:2005+Amd 1:2012, 7.2.13 and 8.4.1.

NOTE 2 Additional information can be found in IEC 60601‑1:2005+Amd 1:2012, 4.2.

Extent of Recognition
Complete standard
Rationale for Recognition
This standard is relevant to medical devices and is recognized on its scientific and technical merit and/or because it supports existing regulatory policies.
Transition Period
FDA recognition of ISO 80601-2-55 First edition 2011-12-15 [Rec# 1-96] will be superseded by recognition of ISO 80601-2-55 Second edition 2018-02 [Rec# 1-140]. FDA will accept declarations of conformity, in support of premarket submissions, to [Rec# 1-96] until September 28, 2019. After this transition period, declarations of conformity to [Rec# 1-96] will not be accepted.
Public Law, CFR Citation(s) and Procode(s)
Regulation Number Device Name Device Class Product Code
§868.1720 Analyzer, Gas, Oxygen, Gaseous-Phase Class 2 CCL
§868.1700 Analyzer, Gas, Nitrous-Oxide, Gaseous Phase (Anesthetic Conc.) Class 2 CBR
§868.1620 Analyzer, Gas, Halothane, Gaseous-Phase (Anesthetic Conc.) Class 2 CBS
§868.1500 Analyzer, Gas, Desflurane, Gaseous-Phase (Anesthetic Concentration) Class 2 NHO
§868.1500 Analyzer, Gas, Enflurane, Gaseous-Phase (Anesthetic Concentration) Class 2 CBQ
§868.1500 Analyzer, Gas, Isoflurane, Gaseous-Phase (Anesthetic Concentration) Class 2 NHQ
§868.1500 Analyzer, Gas, Sevoflurane, Gaseous-Phase (Anesthetic Concentration) Class 2 NHP
§868.1400 Analyzer, Gas, Carbon-Dioxide, Gaseous-Phase Class 2 CCK
Relevant FDA Guidance and/or Supportive Publications
There is no relevant guidance developed at this time.
FDA Technical Contact
 Neel Patel
  FDA/OMPT/CDRH/ODE/DAGID/ANDB/
  301-796-6274
  Neel.Patel@fda.hhs.gov
Standards Development Organization
ISO International Organization for Standardization https://www.iso.org/
FDA Specialty Task Group (STG)
Anesthesiology
-
-